N-[7-oxo-6-(piperidin-4-ylmethyl)-4,5-dihydro-1H-pyrazolo[3,4-c]pyridin-3-yl]naphthalene-1-sulfonamide | 1448687-34-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: N-[7-oxo-6-(piperidin-4-ylmethyl)-4,5-dihydro-1H-pyrazolo[3,4-c]pyridin-3-yl]naphthalene-1-sulfonamide
• CAS: 1448687-34-0
• 化学式: C₂₂H₂₅N₅O₃S
• 分子量: 439.538
• InChiKey: GBWJFJQNRDZCRT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  31
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  116
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  Tert-butyl 4-[(3-cyanopropylamino)methyl]piperidine-1-carboxylate 在 吡啶 、 4-二甲氨基吡啶 、 sodium ethanolate 、 一水合肼 、 溶剂黄146 、 三氟乙酸 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 生成 N-[7-oxo-6-(piperidin-4-ylmethyl)-4,5-dihydro-1H-pyrazolo[3,4-c]pyridin-3-yl]naphthalene-1-sulfonamide
  参考文献：
  名称：

  Synthesis and the 5-HT6 receptor antagonistic effect of 3-arylsulfonylamino-5,6-dihydro-6-substituted pyrazolo[3,4]pyridinones for neuropathic pain treatment

  摘要：

  A novel series of 3-arylsulfonylamino-5,6-dihydro-6-substituted-1H-pyrazolo[3,4-c]pyridine-7-ones was designed and synthesized as 5-HT6 ligands. Among the derivatives synthesized, the lead compound, 12b, having piperidine functionality at the 6-position and (1-naphthyl)sulfonamino at the 3-position of the core structure showed the most potent 5-HT6 inhibitory activity in vitro, good stability without CYP liability, and good neuropathic pain alleviation activity in a rat animal model. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.05.100

文献信息

• Synthesis and the 5-HT6 receptor antagonistic effect of 3-arylsulfonylamino-5,6-dihydro-6-substituted pyrazolo[3,4]pyridinones for neuropathic pain treatment
  作者：Vani Nelamane Devegowda、Jin-Ri Hong、Sungjin Cho、Eun Jeong Lim、Hyunah Choo、Gyochang Keum、Hyewon Rhim、Ghilsoo Nam

  DOI：10.1016/j.bmcl.2013.05.100

  日期：2013.8

  A novel series of 3-arylsulfonylamino-5,6-dihydro-6-substituted-1H-pyrazolo[3,4-c]pyridine-7-ones was designed and synthesized as 5-HT6 ligands. Among the derivatives synthesized, the lead compound, 12b, having piperidine functionality at the 6-position and (1-naphthyl)sulfonamino at the 3-position of the core structure showed the most potent 5-HT6 inhibitory activity in vitro, good stability without CYP liability, and good neuropathic pain alleviation activity in a rat animal model. (C) 2013 Elsevier Ltd. All rights reserved.